The Medical Innovation Playbook details the diverse and rapidly evolving technology commercialization programs of the United States’ top medical centers. It is the first comprehensive effort to profile these programs, and a must-have resource for companies seeking partnerships with academic medical centers and healthcare institutions.
Register for a survey
Each year, nearly $100 billion is spent in the United States on healthcare-related research, with an increasing proportion of the breakthrough research being carried out in medical centers. While continued medical progress relies on enhanced academic-industry collaboration, information about the medical centers’ commercialization system functions is not uniform and difficult to access. The Playbook will include individual organizational profiles, covering the technology commercialization programs of the nation’s top healthcare institutions and academic medical centers. These profiles and related analyses will advance the general understanding of these programs and provide the information needed to enhance collaboration between public and private partners through these initiatives.
Why Participate?
Selection Criteria:
Academic medical centers have been selected for inclusion in the Medical Innovation Playbook based on two criteria: (1) cumulative healthcare research budget; and (2) current measureable outcomes associated with technology commercialization program activities.
Initial Survey: The first step in developing the program profiles is a short on-line survey addressing topics that include an institutional profile, technology commercialization program overview and structure, program operations data, intellectual property policy, and outcome metrics (View PDF of survey)
Download Survey (PDF): Playbook Survey
Follow-Up Interview: A follow-up interview will delve deeper into specific operational, structure and partnership topics.
Profile Development and Compilation: A comprehensive profile developed for each institution is vetted and approved for inclusion in the Medical Innovation Playbook by the participating institution. It will not be published until the institution approves.
View Clinic Profile: Innovation Playbook Profile Cleveland Clinic May 2011
Darren Carroll, Vice President, Corporate Business Development, Eli Lilly and Company
Guy M. Chisolm III, PhD, Professor of Cell Biology and Vice Chair of the Lerner Research Institute, Cleveland Clinic
Christopher Coburn, Executive Director, Cleveland Clinic Innovations
Christopher Colecchi, Managing Director, Broadview Ventures
Candace DeMatteis, Policy Director for the Council for American Medical Innovation
Paul DiCorleto, PhD, Chair, Lerner Research Institute, Cleveland Clinic
Partners Richard N. Foster, PhD, Managing Partner, Millbrook Management Group LLC
Jan Garfinkle, Founder and Managing Director, Arboretum Ventures
Jack Granowitz, Senior Technical Advisor to the Executive Director, STV
Debra Lappin, Principal, FaegreDB Consutling
James Mawson, Global Corporate Venturing
Arundeep Pradhan, Associate Vice President for Technology Transfer and Business Development at Oregon Health & Science University
Harry Rein, General Partner, Foundation Medical Partners
Roy Silverstein, MD, Chairman, Department of Medicine, Medical College of Wisconsin
Steve VanNurden, CEO of Fitzsimmons Redevelopment Authority
Academic medical centers have been selected for inclusion in the Medical Innovation Playbook based on cumulative healthcare research budget and current measureable outcomes associated with technology commercialization program activities.
Register for a survey
Cleveland Clinic: The Playbook
10000 Cedar Avenue/GCIC10
Cleveland, Ohio 44106
